INP Greifswald and neoplas tools GmbH introduce plasma-pen kINPen® MED at medical trade fair in Dusseldorf.
At the international trade fair MEDICA in Düsseldorf, scientists from Greifswald will introduce the first cold plasma-jet with the aim to improve wound healing. Together with its spin-off neoplas tools GmbH the Leibniz Institute of Plasma Science and Technology e.V. (INP Greifswald) will belong from November 12-15 to approximately 4600 exhibitors at the world’s largest medical trade fair.
Their joint innovation: the plasma jet kINPen® MED to treat chronic wounds and pathogen-induced skin diseases. Certification as a medical device was received in collaboration with the University Medicine Greifswald and the Charité – Universitätsmedizin Berlin.
Based on many years of basic research, scientists of the Leibniz Institute in Greifswald verified that physical cold plasmas inactivate pathogens but also multi-resistant bacteria like MRSA Wound healing is stimulated by the anti-bacterial and proliferation-enhancing effects of physical plasma.
Furthermore, clinical trials showed successful treatment of chronic ulcera (open leg ulcer, lower leg sore) with plasma applications. For about 4 million people in Germany suffering from chronic wounds plasma therapy could be an effective alternative to established therapies in wound treatment.
“In the last few years Greifswald became a leading international center of plasma medicine. Our research results served as basis for a successful product development and launch of the kINPen® MED by neoplas tools GmbH”, says the director of the INP Prof. Dr. Klaus-Dieter Weltmann. Just a few days ago neoplas tools GmbH was awarded with the Ludwig-Bölkow technology prize of the federal state of Mecklenburg-Vorpommern to honor the successful transfer of research and development results into commercialization.
Since the start of 2014, the plasma-jet is successfully employed in several clinics and dermatological practices. “We will use the trade fair to present the first therapeutic success and potential of plasma medicine to an international specialists”, explains Renate Schönebeck, General Manager of neoplas tools GmbH, the enterprise in Greifswald manufacturing and distributing the plasma jet.
For the scientists at the INP which are working in the field of application of physical plasmas in medicine is not yet exhausted. “Recent research results suggest that physical plasmas could be used to inactivate cancer cells”, Prof. Weltmann points out.
INP Greifswald and neoplas tools GmbH present their results of plasmamedical research as well as the plasma jet kINPen® MED in hall 15, booth G40. At the shared booth of the Fördergesellschaft WTSH (Wirtschaftsförderung und Technologietransfer Schleswig-Holstein - Promotion of Economic Development and Technology Transfer in Schleswig-Holstein) innovative medical devices of northern federal states are presented.
Please contact us for press enquiries or if you would like to have further information about INP Greifswald as well as the kINPen® MED and neoplas tools GmbH:
Strategic marketing & research transfer
phone: +49 159 – 0401 0814
Cathleen Möbius | Leibniz-Institut für Plasmaforschung und Technologie e.V.
Novel PET imaging agent could help guide therapy for brain diseases
03.04.2018 | Society of Nuclear Medicine and Molecular Imaging
New Computer Architecture: Time Lapse for Dementia Research
29.03.2018 | Deutsches Zentrum für Neurodegenerative Erkrankungen e.V. (DZNE)
At the Hannover Messe 2018, the Bundesanstalt für Materialforschung und-prüfung (BAM) will show how, in the future, astronauts could produce their own tools or spare parts in zero gravity using 3D printing. This will reduce, weight and transport costs for space missions. Visitors can experience the innovative additive manufacturing process live at the fair.
Powder-based additive manufacturing in zero gravity is the name of the project in which a component is produced by applying metallic powder layers and then...
Physicists at the Laboratory for Attosecond Physics, which is jointly run by Ludwig-Maximilians-Universität and the Max Planck Institute of Quantum Optics, have developed a high-power laser system that generates ultrashort pulses of light covering a large share of the mid-infrared spectrum. The researchers envisage a wide range of applications for the technology – in the early diagnosis of cancer, for instance.
Molecules are the building blocks of life. Like all other organisms, we are made of them. They control our biorhythm, and they can also reflect our state of...
University of Connecticut researchers have created a biodegradable composite made of silk fibers that can be used to repair broken load-bearing bones without the complications sometimes presented by other materials.
Repairing major load-bearing bones such as those in the leg can be a long and uncomfortable process.
Study published in the journal ACS Applied Materials & Interfaces is the outcome of an international effort that included teams from Dresden and Berlin in Germany, and the US.
Scientists at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) together with colleagues from the Helmholtz-Zentrum Berlin (HZB) and the University of Virginia...
Novel highly efficient and brilliant gamma-ray source: Based on model calculations, physicists of the Max PIanck Institute for Nuclear Physics in Heidelberg propose a novel method for an efficient high-brilliance gamma-ray source. A giant collimated gamma-ray pulse is generated from the interaction of a dense ultra-relativistic electron beam with a thin solid conductor. Energetic gamma-rays are copiously produced as the electron beam splits into filaments while propagating across the conductor. The resulting gamma-ray energy and flux enable novel experiments in nuclear and fundamental physics.
The typical wavelength of light interacting with an object of the microcosm scales with the size of this object. For atoms, this ranges from visible light to...
13.04.2018 | Event News
12.04.2018 | Event News
09.04.2018 | Event News
24.04.2018 | Information Technology
24.04.2018 | Earth Sciences
24.04.2018 | Life Sciences